Water Damage Restoration Near Me Holly Springs, NC

First responders, including medics and fire crews from Holly Springs Fire Department, worked to assist those suffering from injuries after the crash. While specific details regarding the number of individuals or vehicles involved have not been released, it was confirmed that emergency care was rendered at the scene.

Officials are continuing to assess the circumstances that led to the collision. Additional details are expected to emerge as the inquiry continues.

Our thoughts are with everyone affected by this incident.

Suburban Traffic Safety and Crashes in Holly Springs

Suburban intersections such as GB Alford Hwy and Green Oaks Pkwy in Holly Springs see a mix of residential, commuter, and school traffic throughout the day. Evening hours in particular tend to carry heightened risk as drivers return home, navigate stoplights, or enter commercial zones after work hours.

Motor vehicle crashes in these zones are often caused by distracted driving, sudden turns, or speeding through controlled intersections. The blend of local and through traffic at multi-lane intersections like this one creates a complex environment where minor mistakes can lead to serious consequences.

It is important for those involved in any traffic collision to seek medical attention promptly and consider their legal rights. Injured parties may be entitled to compensation for medical expenses, lost wages, or pain and suffering. Legal professionals can help ensure fair handling of insurance claims and provide clarity on how to proceed.

If you or someone you know has been injured in a crash, contact Local Accident Reports for guidance and support.

Previous

Note: These posts are created solely for the use of Local Accident Reports. We have not verified the information in these posts as the information is gathered from secondary sources. If you have personal knowledge that the information contained in these posts is inaccurate, please contact Local Accident Reports immediately so we can make the necessary corrections or remove the story.

Disclaimer: We are providing this information to the general public as a resource to use in the event you or a family member are injured in a similar incident. Every effort is put forth to honor the victims of accidents, and hope the information presented helps others avoid the same type of accidents in the future. The photos depicted in these posts are not representative of the actual accident scene. Please contact Local Accident Reports at (888) 657-1460 to be connected with an attorney in your area who will answer any legal questions you may have.

The N.C. Economic Investment Committee has approved an economic incentive for the Swiss pharmaceutical company Roche to build a $700 million factory in the Wake County town of Holly Springs.

The committee on Monday awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create these jobs between 2028 and 2032 at an average yearly salary of at least $119,800.

Roche is one of the world’s largest pharmaceutical companies, with a market capitalization above that of IBM, McDonald’s, and AT&T. It entered Monday trading as the world’s 51st most valuable public company.

If it meets these hiring and investment targets, Roche will be eligible to receive up to $9.8 million in payroll tax breaks through a state job development investment grant, or JDIG. North Carolina’s total incentives for the project could reach $13 million.

“World-class companies like Genentech recognize that North Carolina is a leading state for biotechnology,” Gov. Josh Stein said in a statement Monday.

Roche selected Holly Springs over a finalist site in Ohio, the N.C. Economic Investment Committee said Monday. The promised plant will focus on “fill-finish” operations, a later step in the drugmaking process where active ingredients are put into final containers, like vials.

Combined, Holly Springs and Wake County awarded an additional incentive package worth up to $33.5 million over the course of the project.

The Roche project adds to Holly Springs’ existing biotech projects, which include massive incoming facilities from Fujifilm and Amgen. Holly Springs has seen rapid growth in recent decades, with its current population of 46,000 residents nearly doubled from 2010.

“What happened almost 20 years ago, the town council and Mayor Dick Sears at the time said we want to become a life science, bioscience hub. How do we get there?” town council member Tim Forrest told The N&O in December. “So they started gearing infrastructure changes to the land development, water, sewer, all that for pending growth but also for how to recruit major businesses.”

This story was originally published May 12, 2025 at 8:38 AM.

Holly Springs Salamanders catcher Alexia Jorge is making history as the first woman in the Coastal Plain League.

Alexia Jorge, who just finished her senior season playing baseball at Saint Elizabeth's University, was named player of the game Saturday night in the Salamanders' 11-to-1 win over the Carolina Pirates. In that match, she became the first female baseball player to start in a CPL game.

Holly Springs Salamanders Head Coach Brian Rountree said he expects Jorge to start at catcher on Monday against the Catawba Valley Stars.

Before playing at Saint Elizabeth's University, Jorge, from Lyndhurst, New Jersey, was the youngest player on the gold medal-winning U.S. Baseball Women’s National Team.

In 2022, Jorge became the second female catcher in a college baseball game, and in 2024, she became the second woman to start behind the dish in a collegiate game.

'Any girl can do anything'

Jorge's first hit with the Salamanders -- the first hit by a female player in the CPL -- was captured on video during Saturday night's game. On the field, Jorge was asked how it feels to be the CPL's first female baseball player.

"[It's] being able to come out here and show that the work I put in all paid off ... and to be able to show the girls on the stands that they, too, can play baseball one day if they really want to," Jorge said. "Any girl can do anything ... and don't let anybody tell you that you can't do something just because you're a female."

Saturday night, Jorge was seen signing baseballs and photos for her youngest fans.

"Today was history for the Salamanders and myself," Jorge said.

Although she said she felt welcome and supported by her teammates, Jorge described that being the league's first female player can come with some awkwardness.

"The first day was a little shaky, people didn't know what to think, and you get all those weird questions," Jorge said. "People don't know what to say to you or how to react ... [but] I think tonight was a big night for me and the guys to bond and to be able to show them that I can do this too."

Jorge told WRAL News she moved to the Holly Springs area only three days before her first Salamanders game.

"It's beautiful out here ... I love North Carolina," she said. "I love the vibes, I love the team," she said, describing the game as exciting and high-energy. "Performing in front of 1,500 or so fans was pretty cool."

Jorge said she feels a sense of pride being able to pave the wave for other girls to make moves in sports.

Ting Stadium was full of young girls cheering on Jorge on Saturday and Sunday night.

Jorge's presence on the diamond has already left an imprint on kids.

“I think it's cool that she can do anything that boys can do,” one young girl said. “Anything that boys can do girls can do better.”

Salamanders coach Brian Rountree said Jorge would play and likely start in Monday's game against the Catawba Valley Stars.

'Because they told me no'

When WRAL News asked Jorge how she made it to this point, she answered, "Because they told me no."

Jorge said she grew up playing tee-ball with her brother. As she got older, Jorge said she didn't get the recognition she expected in sports.

"Each step of the way, they told me that I can't do it, that I was never good enough, that I'll never beat a guy out for a spot," Jorge said. "Everything you can think of, they've said it to me, and I just took that personally."

Jorge said she turned that negativity into motivation.

"It put me in a pretty good position," Jorge said. "Your haters can be your biggest advocates."

Jorge's mother, Tracy, who was in the stands Saturday night, said her daughter dreams of becoming a professional baseball player.

"This is her dream," Tracy Jorge said. "From a very young age as a little girl she promised herself that she was going to play baseball for the rest of her life. She's working for it."

Jorge's family doesn't live locally, but her mom said she aims to be at every single game.

"I will be at every possible game that I can get to, whether I drive [or] fly, whatever I've got to do to watch my daughter play, I will be there," Tracy Jorge said.

Earlier in May, when the Salamanders announced Jorge would join the team, the CPL called itself an "innovative league that is not afraid to expand the game and tear down barriers."

“Alexia joining the Salamanders marks an exciting moment for the Coastal Plain League,” Chip Allen, CPL commissioner, said. "It reflects the continued growth and evolution of our game, and we’re proud to support opportunities like this across our league as we work to grow the game of baseball.”

“We’re thrilled to add Alexia to our team as she will make CPL history," said Michael Villafana, general manager of the Holly Springs Salamanders. “We can’t wait to see how she makes her impact on the Salamanders this season.”

Holly Springs Salamanders tickets

The Holly Springs Salamanders play at Ting Stadium. Tickets for games start around $10. In June, several themed nights are planned, including Princess & Pirates (June 1), Bark in the Park (June 5), Hawaiian Night (June 6) and Star Wars Night (June 7). View the promotions schedule online.

The Holly Springs Salamanders are owned by Capitol Broadcasting Company.

More On This

Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, 700,000 square-foot manufacturing facility in Holly Springs, a city in the Research Triangle area.

The announcement was made at the company’s DC headquarters by CEO Ashley Magargee, following approval by the North Carolina Department of Commerce’s Economic Investment Committee. This will be Genentech’s first footprint in North Carolina.

“World-class companies like Genentech recognize that North Carolina is a leading state for biotechnology,” said Gov. Josh Stein in a press release. “These companies know that our life science workforce is ready to help them deliver their cutting-edge medicines to the world. We are proud to welcome Genentech to North Carolina.”

Headquartered in San Francisco, California, the company is a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) of Switzerland and is widely recognized as a pioneer in biotechnology, according to a press release. The company has been at the forefront of scientific innovation for over four decades, dedicated to discovering and developing treatments for serious and life-threatening conditions. The Holly Springs facility will serve as a high-volume fill-finish operation. This expansion will support its current portfolio and future pipeline, enhancing Genentech’s ability to meet the growing global demand for its medicines.

“Genentech would like to thank Governor Stein and Commerce Secretary Lilley for their support and for welcoming us to North Carolina,” Magargee said in a press release. “We are thrilled to establish this relationship with the city of Holly Springs, where we will create new manufacturing and construction jobs while making a broader positive impact on the local economy and community for many years to come.”

The new facility will be partially funded through a Job Development Investment Grant (JDIG), and the project is estimated to grow by more than $3 billion over a 12-year term.

Under the JDIG agreement, the company may receive up to $9,846,750 in potential reimbursements over 12 years, contingent upon creating 420 jobs. These state payments are issued only after the Departments of Commerce and Revenue confirm that the company has achieved its job creation and investment targets.

Additional incentives comprise $756,000 from the North Carolina Community College System, $827,400 from the Department of Commerce’s Division of Workforce Solutions, $19.7 million from Wake County, and $13.7 million from the Town of Holly Springs, according to a press release from Genentech.

According to a press release from the governor, the project is expected to yield a 230% return on the public investment. The governor’s statement also claims JDIG initiatives consistently generate a net positive tax return for the state treasury, even after accounting for the reimbursement payments made to participating companies.

“While the JDIG is often praised as a powerful engine for job creation, a closer look tells a different story,” Joseph Harris, fiscal policy analyst for the John Locke Foundation, told the Carolina Journal. “According to a recent report, from 2003 through 2024, 203 out of 426 agreements have been terminated or withdrawn before fulfilling their job creation targets. This high failure rate raises serious questions about the program’s effectiveness and whether it delivers on its promises to taxpayers.”

Salaries will vary depending on the position, but the average salary will be $119,833, over $40,000 more than the average Wake County salary of $76,643. The new positions are expected to have an annual payroll impact of more than $50 million.

“In Gov. Josh Stein’s recent budget proposal, he recommended halting across-the-board income tax cuts for all corporations; meanwhile, he has promoted providing economic incentive deals to select corporations, such as Genentech,” said Harris. “This hypocritical stance toward corporate taxation mirrors the position of former Gov. Roy Cooper during his tenure.”

This is not the first pharmaceutical company funded by JDIG to come to Holly Springs. Amgen broke ground on an expansion back in January.

Biotech pioneer Genentech plans to invest $700 million and create 420 jobs in the Wake County town of Holly Springs. Genentech, a subsidiary of Switzerland-based Roche Holdings, plans to pay an average annual wage of $119,833 over five years, beginning in 2028 and make the investment by Dec. 31, 2030, according to the state Economic Investment Committee.

Wake County’s current average pay is $76,643.

South San Francisco-based Genentech makes medicines for people with serious and life-threatening conditions. It created the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The company has more than 13,500 employees, more than 40 medicines on the market and has had 39 FDA breakthrough therapy designations. Roche currently has more than 400 employees in North Carolina, including 29 who work for Genentech.

Genentech will build a 700,000-square-foot, high-volume fill-finish operation to support its existing product portfolio and meet demand for its medicines, according to the state. It will be Genentech’s first East Coast production facility.

Genentech looked at more than 60 locations before deciding on Holly Springs. The final decision came down to Holly Springs and another site in Ohio.

The state’s Economic Investment Committee awarded Genentech a Job Development Investment Grant of $9.8 million, payable over 12 years, on Monday. Holly Springs and Wake County added $33.5 million in investment grants. The grants are only payable if Genentech meets investment and job growth targets. The project’s projected return on investment of public dollars is 230%, meaning for every dollar of potential cost, the state receives $3.30 in state revenue.

Genentech will also receive job training help from the community college system, worth about $1.5 million.

Holly Springs, a town of about 46,000 residents in southwest Wake County, is already home to several life science companies. Other companies in Holly Springs include CSL Seqirus, which has a large flu vaccine manufacturing plant, FUJIFILM Diosynth Biotechnologies, which has a biopharmaceutical manufacturing facility, and the biotechnology company Amgen.

The shares of Krispy Kreme lost almost a quarter of their value after the Charlotte-based doughnut retailer withdrew its previous full-year financial forecast, partly due to an unprofitable start for its national McDonald’s rollout. Shares closed at $3.26, down 24.7%.

First quarter revenue sank 15.3% to $375.2 million, hurt by last year’s sale of a majority stake in Insomnia Cookies and a U.S. consumer pullback that offset an increasing number of locations selling doughnuts, the company said in a statement.

Krispy Kreme also discontinued its quarterly cash dividend of 3½ cents a share, after saying in its annual securities filing in February it expected to continue paying a dividend, with the final quarterly payout to shareholders on Wednesday, May 7. It plans to redirect the money to reducing debt.

“In this challenging macro environment, we are prioritizing paying down debt and deleveraging our balance sheet, generating positive cash flow and pursuing only profitable growth based on sustainable revenue streams,” CEO Josh Charlesworth told analysts on a conference call.

In a blow to its national expansion, Krispy Kreme is pausing the addition of new McDonald’s restaurants until it can figure out how to generate profitable sales through the fast-food giant’s outlets. Since last year, it’s begun selling in more than 2,400 McDonald’s locations.

“We are seeing that after the initial marketing launch, demand drops below our expectations,” said Charlesworth, explaining the decision to add no new McDonald’s distribution in the second quarter. While confident about long-term prospects, he said, “We really need to make sure we’re positioned for profitable growth before we expand any further.”

Last quarter, Krispy Kreme began outsourcing doughnut delivery, part of its effort to simplify operations. Aiming to improve efficiencies, it’s going to curb sales in lower-volume regional grocery chains and convenience stores. It’s also reducing the number of days it offers discounts while focusing on efforts to sell its original glazed doughnut, relatively inexpensive for customers and more profitable for the company.

Krispy Kreme is also seeking to spur sales with improvements to drive-throughs, offering larger packages in membership club stores and adding secondary displays in discount and supermarkets.

“Given the scope of these actions, the macroeconomic softness and uncertainty with McDonald’s, we are withdrawing our prior full year outlook and not updating it at this time,” CFO Jeremiah Ashukian told analysts.

In February, the company projected organic revenue growth of 5% to 7%, with net revenue of $1.55 billion to $1.65 billion and adjusted EPS of 4 cents to 8 cents.

Krispy Kreme estimated $5 million in operational inefficiencies related to an information technology hack last year. At that time, it said in a securities filing it anticipated that the loss of online sales and other costs from the cybersecurity incident will result in “a material impact” on the company’s business operations and finances.

Looking ahead, Charlesworth told analysts Krispy Kreme plans to open five to seven production hubs this year, mainly to improve coverage for national customers such as Target Corp.